Merck Provides Update on KEYNOTE-407 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. MU
8. DFTX
9. HOOD
10. RGNX

Go back to Merck Provides Update on KEYNOTE-407 Trial
Merck & Co. (NYSE: MRK) Delayed: 114.78 +0.91 (0.80%)
Previous Close $113.87    52 Week High $65.46 
Open $113.97    52 Week Low $47.97 
Day High $115.56    P/E 78.08 
Day Low $113.00    EPS $1.47 
Volume 5,842,267